Why the study?
Does growth hormone replacement improve cardiac contractility and myofilament force generation in aged rats?
Does growth hormone replacement improve cardiac contractility and myofilament force generation in aged rats?
In a rat model, growth hormone replacement reversed age-related declines in cellular myofilament contractility but did not restore overall left ventricular developed pressure.
Answers are grounded in this paper and cite their sources.
GH replacement may target myofilament dysfunction in aging; hypothesis-generating and should not yet inform clinical practice.
We tested the hypotheses that aging is associated with a reduction in overall cardiac contractility and myofilament force generation that could be reversed with growth hormone (GH) replacement. Three groups of male Brown-Norway rats were studied: young (Y(SAL): 8 mo old, n = 13), old (O(SAL): 28 mo old, n = 13), and old GH-treated (O(GH): 28 mo old, n = 12; 300 microg bovine GH, twice a day for 30 days). The left ventricular (LV) pressure-volume relation was derived in isolated hearts, after which isolated trabecular muscles from these hearts were permeabilized and maximal myofilament force generation (Fmax) was measured. LV developed pressures at a LV volume of 0.3 ml were significantly depressed with age: 84 +/- 6 vs. 71 +/- 6 mmHg (Y(SAL) vs. O(SAL), respectively, P = 0.001) and not restored by GH (69 +/- 4 mmHg). Fmax was reduced in the aged hearts: 47.5 +/- 3.12 vs. 35.9 +/- 3.03 mN/mm2 (Y(SAL) vs. O(SAL), respectively, P = 0.014) but was restored with GH replacement to 46.7 +/- 3.12 mN/mm2 (O(SAL) vs. O(GH), P = 0.021). Our results suggest that cellular myofilament contractility is reduced with aging and restored with GH replacement.
No takes yet. Share an insight, caveat, or question.
Wannenburg et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: